Benitec Biopharma (BNTC) Amortizatization of Intangibles (2019 - 2025)
Benitec Biopharma (BNTC) reported Amortizatization of Intangibles of $106000.0 for Q4 2025, up 260.61% on a YoY basis from $29395.0 in Q4 2024, and up 0.95% sequentially from $105000.0 in Q3 2025.
Benitec Biopharma (BNTC) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends
Benitec Biopharma (BNTC) has 7 years of Amortizatization of Intangibles data on file, last reported at $106000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles rose 260.61% year-over-year to $106000.0; the trailing twelve-month figure through Dec 2025 stood at $541000.0 (up 316.15% YoY), and the FY2025 full-year result was $330000.0, up 28.91% from the prior year.
- Amortizatization of Intangibles improved to $106000.0 in Q4 2025, from $105000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $330000.0 in Q2 2025 to a low of -$66000.0 in Q4 2024.
- A 5-year average of $71842.1 and a median of $61000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles slumped 204.76% in 2024 and soared 407.69% in 2025, its largest moves.
- Tracing BNTC's Amortizatization of Intangibles over 5 years: stood at $58000.0 in 2021, then rose by 5.17% to $61000.0 in 2022, then increased by 3.28% to $63000.0 in 2023, then tumbled by 204.76% to -$66000.0 in 2024, then soared by 260.61% to $106000.0 in 2025.
- Business Quant data shows BNTC's Amortizatization of Intangibles at $106000.0 in Q4 2025, $105000.0 in Q3 2025, and $330000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Benitec Biopharma | 535.10 Mn | 346.20 Mn | - | 106,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 106,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Sep 30, 2025 | 105,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 330,000.00 |
| Dec 31, 2024 | -66,000.00 |
| Dec 31, 2024 | -66,000.00 |
| Sep 30, 2024 | 66,000.00 |
| Sep 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Jun 30, 2024 | 65,000.00 |
| Mar 31, 2024 | 65,000.00 |
| Mar 31, 2024 | 65,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Dec 31, 2023 | 63,000.00 |
| Sep 30, 2023 | 63,000.00 |
| Sep 30, 2023 | 63,000.00 |
| Jun 30, 2023 | 63,000.00 |
| Jun 30, 2023 | 63,000.00 |